Noroclav Tablets 250mg Blister Pack of
NORBROOK LABS
Noroclav Tablets 250mg Blister Pack of from NORBROOK LABS is supplied as a tablet.
LEGAL CLASSIFICATION:POM-V
THIS MEDICINE REQUIRES A PRESCRIPTION.
This can be uploaded on this page or it can be sent to mail@vets4u.uk.
We also require information about you and your Pet for us to be able to dispense your Pets medicine, please provide us with all your up to date information in the Question boxes below.
A link to the Medicine SPC on the VMD Product database can be found here: VMD Product Database
Post-Authorisation Assessment Report: PAAR (PDF)
Read the full Noroclav product information ›
Active Ingredient(s)
Amoxicillin, Clavulanic Acid
Pack & Presentation
Form: Tablet · Pack size: PK 250
Suitable Species
Dogs
Indications
Treatment of the following infections caused by Beta-lactamase producing strains of bacteria sensitive to amoxicillin in combination with clavulanic acid: • Skin infections (including superficial and deep pyodermas) caused by susceptible Staphylococci • Urinary tract infection caused by susceptible Staphylococci or Escherichia coli • Respiratory infections caused by susceptible Staphylococci • Enteritis caused by susceptible Escherichia coli It is recommended to carry out suitable tests for sensitivity testing when initiating the treatment. The treatment should only proceed if sensitivity is proven to the combination.
Storage & Shelf Life
Do not store above 25°C. Store in the original package in order to protect from moisture.
Owner Handling & Safety
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to crossreactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.
Contraindications & Warnings
Do not use in animals with known hypersensitivity to penicillin or other substances of the beta-lactam group. Do not use in rabbits, guinea pigs, hamsters or gerbils. Do not use in animals with serious dysfunction of the kidneys accompanied by anuria and oliguria.
Use in Pregnancy & Lactation
Studies in laboratory animals have not produced any evidence of teratogenic, effects. Use only according to the benefit/risk assessment by the responsible veterinarian.
Regulatory Information
- Legal category: POM-V
- Marketing authorisation holder: Norbrook Laboratories Limited, Station Works, Newry, Co. Down, BT35 6JP, Northern Ireland
- MA number: Vm 02000/4212
Important Notice
The information on this page is provided for general guidance only and does not replace the advice of a qualified veterinary surgeon. Always follow the directions provided on the product packaging and by your veterinary practice. If your animal's condition does not improve, worsens, or any side effects occur, contact your veterinary surgeon immediately.
